MENU
PSTV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Plus Therapeutics (PSTV) Earnings Date & Reports

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases... Show more

A.I. Advisor
published Earnings

PSTV is expected to report earnings to fall 75.50% to -12 cents per share on August 16

Plus Therapeutics PSTV Stock Earnings Reports
Q2'23
Est.
$-0.12
Q4'24
Missed
by $0.01
Q1'23
Est.
$-0.14
Q4'22
Missed
by $0.62
Q3'22
Beat
by $0.01
The last earnings report on March 31 showed earnings per share of -50 cents, missing the estimate of -49 cents. With 932.44K shares outstanding, the current market capitalization sits at 13.39M.
View a ticker or compare two or three
PSTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4200 Marathon Boulevard
Phone
+1 737 255-7194
Employees
20
Web
https://www.plustherapeutics.com